US Pharma MarketingIran war disruptions begin to emerge upstream of the pharma supply chain
Evonik on Tuesday said it is increasing its prices by 15% effective immediately for its amino and keto acid products due to rising energy, raw material and shipping expenses caused by the Iran war. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech:…
As the Iran war enters its third month, its knock-on effects on raw materials, energy costs and shipping are beginning to be felt in the pharma industry.
While the Middle East is barely a player ...
Source: Endpoints News